368 related articles for article (PubMed ID: 33562134)
1. Estrogen Receptor Beta: The Promising Biomarker and Potential Target in Metastases.
Božović A; Mandušić V; Todorović L; Krajnović M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562134
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer.
Skjefstad K; Grindstad T; Khanehkenari MR; Richardsen E; Donnem T; Kilvaer T; Andersen S; Bremnes RM; Busund LT; Al-Saad S
Steroids; 2016 Sep; 113():5-13. PubMed ID: 27234503
[TBL] [Abstract][Full Text] [Related]
3. Loss of estrogen receptor Beta expression in follicular thyroid carcinoma predicts poor outcome.
Heikkilä A; Hagström J; Mäenpää H; Louhimo J; Siironen P; Heiskanen I; Haglund C; Arola J
Thyroid; 2013 Apr; 23(4):456-65. PubMed ID: 23106428
[TBL] [Abstract][Full Text] [Related]
4. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
Chang EC; Frasor J; Komm B; Katzenellenbogen BS
Endocrinology; 2006 Oct; 147(10):4831-42. PubMed ID: 16809442
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptors in breast carcinogenesis and endocrine therapy.
Huang B; Warner M; Gustafsson JÅ
Mol Cell Endocrinol; 2015 Dec; 418 Pt 3():240-4. PubMed ID: 25433206
[TBL] [Abstract][Full Text] [Related]
6. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.
Williams C; Edvardsson K; Lewandowski SA; Ström A; Gustafsson JA
Oncogene; 2008 Feb; 27(7):1019-32. PubMed ID: 17700529
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspects.
Omoto Y; Iwase H
Cancer Sci; 2015 Apr; 106(4):337-43. PubMed ID: 25611678
[TBL] [Abstract][Full Text] [Related]
8. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
[TBL] [Abstract][Full Text] [Related]
9. Duality of estrogen receptor β action in cancer progression.
Guillette TC; Jackson TW; Belcher SM
Curr Opin Pharmacol; 2018 Aug; 41():66-73. PubMed ID: 29772419
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma.
Fixemer T; Remberger K; Bonkhoff H
Prostate; 2003 Feb; 54(2):79-87. PubMed ID: 12497580
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer.
Yamashita H; Nishio M; Kobayashi S; Ando Y; Sugiura H; Zhang Z; Hamaguchi M; Mita K; Fujii Y; Iwase H
Breast Cancer Res; 2005; 7(5):R753-64. PubMed ID: 16168121
[TBL] [Abstract][Full Text] [Related]
12. Promyelocytic Leukemia (PML) gene regulation: implication towards curbing oncogenesis.
Datta N; Islam S; Chatterjee U; Chatterjee S; Panda CK; Ghosh MK
Cell Death Dis; 2019 Sep; 10(9):656. PubMed ID: 31506431
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.
Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC
J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659
[TBL] [Abstract][Full Text] [Related]
14. Methylation of ERβ 5'-untranslated region attenuates its inhibitory effect on ERα gene transcription and promotes the initiation and progression of papillary thyroid cancer.
Xu LW; Gou X; Yang JY; Jiang R; Jiang X; Chen GG; Liu ZM
FASEB J; 2021 Apr; 35(4):e21516. PubMed ID: 33710697
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor β upregulated by lncRNA-H19 to promote cancer stem-like properties in papillary thyroid carcinoma.
Li M; Chai HF; Peng F; Meng YT; Zhang LZ; Zhang L; Zou H; Liang QL; Li MM; Mao KG; Sun DX; Tong MY; Deng ZQ; Hou ZJ; Zhao Y; Li J; Wang XC; Lv SS; Zhang QQ; Yu X; Lam EW; Liu Q; Cui XN; Xu J
Cell Death Dis; 2018 Nov; 9(11):1120. PubMed ID: 30389909
[TBL] [Abstract][Full Text] [Related]
16. Should endocrine therapy still be used as an initial treatment for postmenopausal women with metastatic breast cancer?
Orlando L; Cinieri S
Future Oncol; 2017 Jul; 13(16):1361-1364. PubMed ID: 28685586
[No Abstract] [Full Text] [Related]
17. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
Cho MA; Lee MK; Nam KH; Chung WY; Park CS; Lee JH; Noh T; Yang WI; Rhee Y; Lim SK; Lee HC; Lee EJ
J Endocrinol; 2007 Nov; 195(2):255-63. PubMed ID: 17951536
[TBL] [Abstract][Full Text] [Related]
18. Targeting estrogen receptors in colorectal cancer.
Maingi JW; Tang S; Liu S; Ngenya W; Bao E
Mol Biol Rep; 2020 May; 47(5):4087-4091. PubMed ID: 32246248
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target.
Skliris GP; Leygue E; Watson PH; Murphy LC
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):1-10. PubMed ID: 18243688
[TBL] [Abstract][Full Text] [Related]
20. Estrogen enhances mismatch repair by induction of MLH1 expression via estrogen receptor-β.
Lu JY; Jin P; Gao W; Wang DZ; Sheng JQ
Oncotarget; 2017 Jun; 8(24):38767-38779. PubMed ID: 28404976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
